Clover Health Investments (CLOV) Tops Q3 EPS by 2c ; Offers Guidance

Clover Health Investments (NASDAQ: CLOV) reported Q3 EPS of ($0.02), $0.02 better than the analyst estimate of ($0.04). Revenue for the quarter came in at $331 million versus the consensus estimate of $346.27 million.

GUIDANCE:

Clover Health Investments sees FY2024 revenue of $1.35-1.37 billion, versus the consensus of $1.39 billion.

For earnings history and earnings-related data on Clover Health Investments (CLOV) click here.

You May Also Be Interested In

• Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
• Eledon Pharmaceuticals, Inc. (ELDN) Misses Q2 EPS by 12c
• MapLight Therapeutics, Inc. (MPLT) Misses Q2 EPS by 33c